Early left heart decompression protects the lungs in a canine model of acute left heart failure being treated with venoarterial extracorporeal membrane oxygenation.

IF 2.8 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Frontiers in Cardiovascular Medicine Pub Date : 2025-09-24 eCollection Date: 2025-01-01 DOI:10.3389/fcvm.2025.1545903
Yali Chen, Tiewei Xu, Qin Zhen, Changping Gan, Yan Kang, Peng Ji
{"title":"Early left heart decompression protects the lungs in a canine model of acute left heart failure being treated with venoarterial extracorporeal membrane oxygenation.","authors":"Yali Chen, Tiewei Xu, Qin Zhen, Changping Gan, Yan Kang, Peng Ji","doi":"10.3389/fcvm.2025.1545903","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Nearly 30% of patients who undergo venoarterial extracorporeal membrane oxygenation (VA-ECMO) suffer pulmonary edema, which increases mortality risk. Left heart decompression is widely considered an effective way to counter left ventricular dilatation during VA-ECMO, but whether decompression can protect the lung or improve prognosis is unclear. We investigated this question using a canine model of acute left heart failure being treated through VA-ECMO.</p><p><strong>Methods: </strong>The left anterior descending artery was ligated in 12 beagles to induce acute heart failure, and starting 1 h later, animals were treated using femoral-femoral VA-ECMO for 3 h. In half the animals, left heart decompression was initiated concurrently with VA-ECMO. In the other half, decompression was initiated 1 h after VA-ECMO began. The \"early decompression\" and \"late decompression\" groups were compared in terms of pulmonary function, cardiac function, hemodynamics, histopathology and inflammatory responses.</p><p><strong>Results: </strong>Early initiation of decompression led to significantly higher PaO<sub>2</sub> (63.27 ± 3.35 vs. 24.70 ± 4.44 mmHg, <i>P</i> = 0.030), lower PaCO<sub>2</sub> (31.65 ± 2.87 vs. 41.02 ± 4.88 mmHg, <i>P</i> = 0.014), smaller alveolar-arterial oxygen pressure difference, weaker transpulmonary pressure gradient (3.67 ± 3.14 vs. 13.35 ± 4.26 mmHg, <i>P</i> = 0.017), milder pulmonary edema, lower levels of pro-inflammatory cytokines TNF-α and IL-6 in lungs, lower left atrial pressure, lower left ventricular end diastolic pressure, lower mean pulmonary artery pressure, and higher mean arterial pressure. Earlier decompression also led to milder pulmonary blood congestion and pulmonary histopathology.</p><p><strong>Conclusion: </strong>Left heart decompression, when initiated as soon as possible during VA-ECMO, can protect pulmonary function by alleviating inflammatory responses in the lung, improving hemodynamics and lowering ventricular filling pressure.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"12 ","pages":"1545903"},"PeriodicalIF":2.8000,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12504222/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Cardiovascular Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fcvm.2025.1545903","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Nearly 30% of patients who undergo venoarterial extracorporeal membrane oxygenation (VA-ECMO) suffer pulmonary edema, which increases mortality risk. Left heart decompression is widely considered an effective way to counter left ventricular dilatation during VA-ECMO, but whether decompression can protect the lung or improve prognosis is unclear. We investigated this question using a canine model of acute left heart failure being treated through VA-ECMO.

Methods: The left anterior descending artery was ligated in 12 beagles to induce acute heart failure, and starting 1 h later, animals were treated using femoral-femoral VA-ECMO for 3 h. In half the animals, left heart decompression was initiated concurrently with VA-ECMO. In the other half, decompression was initiated 1 h after VA-ECMO began. The "early decompression" and "late decompression" groups were compared in terms of pulmonary function, cardiac function, hemodynamics, histopathology and inflammatory responses.

Results: Early initiation of decompression led to significantly higher PaO2 (63.27 ± 3.35 vs. 24.70 ± 4.44 mmHg, P = 0.030), lower PaCO2 (31.65 ± 2.87 vs. 41.02 ± 4.88 mmHg, P = 0.014), smaller alveolar-arterial oxygen pressure difference, weaker transpulmonary pressure gradient (3.67 ± 3.14 vs. 13.35 ± 4.26 mmHg, P = 0.017), milder pulmonary edema, lower levels of pro-inflammatory cytokines TNF-α and IL-6 in lungs, lower left atrial pressure, lower left ventricular end diastolic pressure, lower mean pulmonary artery pressure, and higher mean arterial pressure. Earlier decompression also led to milder pulmonary blood congestion and pulmonary histopathology.

Conclusion: Left heart decompression, when initiated as soon as possible during VA-ECMO, can protect pulmonary function by alleviating inflammatory responses in the lung, improving hemodynamics and lowering ventricular filling pressure.

早期左心减压对急性左心衰竭犬模型肺的保护作用,该模型采用静脉动脉体外膜氧合治疗。
背景:近30%接受静脉动脉体外膜氧合(VA-ECMO)的患者发生肺水肿,这增加了死亡风险。在VA-ECMO中,左心减压被广泛认为是对抗左室扩张的有效方法,但减压是否能保护肺或改善预后尚不清楚。我们通过VA-ECMO治疗的急性左心衰犬模型研究了这个问题。方法:12只小猎犬结扎左前降支诱导急性心力衰竭,1 h后开始行股股VA-ECMO治疗3 h。在一半的动物中,左心减压与VA-ECMO同时开始。另一半患者在VA-ECMO开始1小时后开始减压。比较“早期减压”组和“晚期减压”组肺功能、心功能、血流动力学、组织病理学和炎症反应。结果:早期开始减压导致显著高于PaO2(63.27±3.35和24.70±4.44毫米汞柱,P = 0.030),降低PaCO2(31.65±2.87和41.02±4.88毫米汞柱,P = 0.014),小alveolar-arterial氧压差,弱transpulmonary压力梯度(3.67±3.14和13.35±4.26毫米汞柱,P = 0.017),较温和的肺水肿,低水平的促炎细胞因子TNF -α和il - 6在肺,降低左心室压力,降低左心室舒张压,平均肺动脉压较低,平均动脉压较高。早期减压也导致轻度肺血充血和肺组织病理学。结论:VA-ECMO时尽早开始左心减压可通过减轻肺内炎症反应、改善血流动力学、降低心室充盈压等方式保护肺功能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Frontiers in Cardiovascular Medicine
Frontiers in Cardiovascular Medicine Medicine-Cardiology and Cardiovascular Medicine
CiteScore
3.80
自引率
11.10%
发文量
3529
审稿时长
14 weeks
期刊介绍: Frontiers? Which frontiers? Where exactly are the frontiers of cardiovascular medicine? And who should be defining these frontiers? At Frontiers in Cardiovascular Medicine we believe it is worth being curious to foresee and explore beyond the current frontiers. In other words, we would like, through the articles published by our community journal Frontiers in Cardiovascular Medicine, to anticipate the future of cardiovascular medicine, and thus better prevent cardiovascular disorders and improve therapeutic options and outcomes of our patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信